Innoviva Inc news

   Watch this stock
Showing stories 1 - 10 of about 81   

Articles published

INVA 11.52 -0.14 (-1.20%)
price chart
Innoviva: Strong Upside As Fears Subside
While at first sight disappointing, the new debt repayment plan actually is pretty bullish for the stock. With generic Advair finally close to hit the market, Innoviva has probably little to be afraid of. Both Breo and Anoro are doing well and forward ...
GlaxoSmithKline (GSK) and Innoviva (INVA) Announce Positive Results for Relvar ...
GlaxoSmithKline plc (NYSE: GSK) and Innoviva, Inc. (NASDAQ: INVA) today announced positive headline results from a non-inferiority lung function study, which demonstrated that patients with well-controlled asthma were able to switch to the once-daily ...
GlaxoSmithKline Reports Positive Resultsfrom Relvar Ellipta Lung Function Study  Nasdaq
Glaxo posts positive asthma-drug study results  MarketWatch
Stock Returns: Innoviva Inc (NASDAQ:INVA) versus SciClone Pharmaceuticals Inc ...
This is a snapshot to compare the stock returns for Innoviva Inc (NASDAQ:INVA) versus SciClone Pharmaceuticals Inc (NASDAQ:SCLN) .
Innoviva Reports Fourth Quarter and Full Year 2016 Financial Results
Innoviva, Inc. (INVA) today reported financial results for the fourth quarter and year ended December 31, 2016. Gross royalties earned on net sales of RELVAR�/BREO� ELLIPTA� and ANORO� ELLIPTA� from Glaxo Group Limited (GSK) during the fourth ...
Innoviva Inc.
Innoviva Inc. NASDAQ: INVA. GO. Set Alerts · Find a Broker · Join TD Ameritrade · Market Index · Overview Profile News Charts Financials Historical Quotes Analyst Estimates Options SEC Filings Insiders.
Fiscal Year Earnings Estimate on Innoviva, Inc.(INVA)
Innoviva, Inc.(INVA): For the most recent quarter end, Innoviva, Inc. reported Annual Earnings of $0.25.
Innoviva: On Track To Buy Back The Whole Company
I have already reviewed the performance of GSK's (NYSE:GSK) new respiratory drugs in another article, so this one will focus on the issues specific to its development partner Innoviva (NASDAQ:INVA) (formerly called Theravance). Innoviva ended 2015 with ...
Innoviva Inc. (INVA) Moves Higher on Volume Spike for February 10
Innoviva Inc. (INVA) traded on unusually high volume on Feb. 10, as the stock gained 0.27% to close at $11.13. On the day, Innoviva Inc. saw 2.14 million shares trade hands on 15,286 trades. Considering that the stock averages only a daily volume of ...
Innoviva, Inc. (INVA) Shares Sold by Empyrean Capital Partners LP  The Cerbat Gem
Innoviva, Inc. (INVA) Announces Earnings Results  Sports Perspectives
Innoviva: Finally Starting To Gain Some Trust
The Innoviva (NASDAQ:INVA) report came one day after GlaxoSmithKline (NYSE:GSK) had already disclosed Q2 sales figures for the partnered drugs Breo and Anoro.
Innoviva Inc Stock Volatility Hits An Extreme Low
This is a proprietary realized volatility rating created by Capital Market Laboratories (CMLviz) based on a large number of data interactions for Innoviva Inc (NASDAQ:INVA) . We examine the little used gem of daily stock volatility over a 20-day and 30 ...